{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:15Z","timestamp":1790712435590,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109748","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T11:18:51Z","timestamp":1675682331000},"page":"109748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["STAT3 regulation of Mtb-specific T cell function in active pulmonary tuberculosis patients"],"prefix":"10.1016","volume":"116","author":[{"given":"Ruiqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109748_b0005","unstructured":"World Health Organization (WHO) .Global Tuberculosis Report 2021. Geneva,WHO,2021.www.who.int\/tb\/publications\/global_report\/en\/[Google Scholar]."},{"issue":"11","key":"10.1016\/j.intimp.2023.109748_b0010","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.rmed.2006.08.006","article-title":"The history of tuberculosis","volume":"100","author":"Daniel","year":"2006","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.109748_b0015","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1183\/09031936.04.00072604","article-title":"On the nature of Mycobacterium tuberculosis-latent bacilli","volume":"24","author":"Cardona","year":"2004","journal-title":"Eur. Respir. J."},{"issue":"22","key":"10.1016\/j.intimp.2023.109748_b0020","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.109748_b0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0952-7915(95)80096-4","article-title":"The protective immune response to Mycobacterium tuberculosis","volume":"7","author":"Cooper","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2023.109748_b0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109748_b0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fimmu.2017.00967","article-title":"Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?","volume":"8","author":"Chore\u00f1o Parra","year":"2017","journal-title":"Front. Immunol."},{"issue":"4216","key":"10.1016\/j.intimp.2023.109748_b0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1105787","article-title":"Mefloquine (WR 142,490) in the treatment of human malaria","volume":"190","author":"Trenholme","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2023.109748_b0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.181.1.116","article-title":"Programmed death (PD)-1:PD-ligand 1\/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis","volume":"181","author":"Jurado","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109748_b0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/infdis\/jit206","article-title":"Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon \u03b3-producing T cells from apoptosis in patients with pulmonary tuberculosis","volume":"208","author":"Singh","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2023.109748_b0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2014.06.002","article-title":"Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy","volume":"62","author":"Chowdhury","year":"2014","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109748_b0060","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1164\/rccm.200909-1463OC","article-title":"Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109748_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-13-13","article-title":"Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis","volume":"13","author":"Masood","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.intimp.2023.109748_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2023.109748_b0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.smim.2014.10.004","article-title":"SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis","volume":"26","author":"Rottenberg","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2023.109748_b0080","unstructured":"Diagnostic criteria for tuberculosis (WS 288-2017), Electron. J. Emerg. Infect. Dis. 3(01) (2018) 59\u201361."},{"issue":"5","key":"10.1016\/j.intimp.2023.109748_b0085","first-page":"180","article-title":"Functional signatures of human CD4 and CD8T cell responses to Mycobacterium tuberculosis","volume":"22","author":"Prezzemolo","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109748_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/cmi.2018.5","article-title":"Constitutive STAT3 phosphorylation and IL-6\/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients","volume":"16","author":"Harling","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2023.109748_b0095","doi-asserted-by":"crossref","first-page":"16777","DOI":"10.1074\/jbc.M207999200","article-title":"Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease","volume":"278","author":"Lovato","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109748_b0100","doi-asserted-by":"crossref","unstructured":"K. Kuuliala, A. Kuuliala, R. Koivuniemi, et al. Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis.PLoS One. 2015;10(9), e0137385. Published 2015 Sep 9. 10.1371\/journal.pone.0137385.","DOI":"10.1371\/journal.pone.0137385"},{"issue":"6","key":"10.1016\/j.intimp.2023.109748_b0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/rheumatology\/keu430","article-title":"The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels","volume":"54","author":"Isom\u00e4ki","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2023.109748_b0110","doi-asserted-by":"crossref","first-page":"17663","DOI":"10.1038\/srep17663","article-title":"Multiple regulation pathways and pivotal biological functions of STAT3 in cancer","volume":"5","author":"Yuan","year":"2015","journal-title":"Sci. Rep."},{"issue":"40","key":"10.1016\/j.intimp.2023.109748_b0115","doi-asserted-by":"crossref","first-page":"41679","DOI":"10.1074\/jbc.M406413200","article-title":"Alternative activation of STAT1 and STAT3 in response to interferon-gamma","volume":"279","author":"Qing","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2023.109748_b0120","doi-asserted-by":"crossref","first-page":"e1005490","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2023.109748_b0125","doi-asserted-by":"crossref","first-page":"38362","DOI":"10.1038\/srep38362","article-title":"PD-1\/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109748_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2018.06.011","article-title":"The exhausted CD4+CXCR5+ T cells involve the pathogenesis of human tuberculosis disease","volume":"74","author":"Jean Bosco","year":"2018","journal-title":"Int. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.109748_b0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxq446","article-title":"PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Gu\u00e9rin","volume":"22","author":"Sakai","year":"2010","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109748_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14728222.2018.1471137","article-title":"Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells","volume":"22","author":"Sasidharan Nair","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.intimp.2023.109748_b0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/314667","article-title":"Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis","volume":"179","author":"Hirsch","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.109748_b0150","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2012.11.013","article-title":"Shedding light on apoptosis at subcellular membranes","volume":"151","author":"Kale","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2023.109748_b0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2023.109748_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107898","article-title":"Multifunctional T cell response in active pulmonary tuberculosis patients","volume":"99","author":"Qin","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109748_b0165","doi-asserted-by":"crossref","unstructured":"R.A. Seder, P.A. Darrah, M. Roederer. T-cell quality in memory and protection: implications for vaccine design [published correction appears in Nat Rev Immunol. 2008 Jun;8(6), 486]. Nat Rev Immunol. 2008;8(4), 247\u2013258. 10.1038\/nri2274.","DOI":"10.1038\/nri2274"},{"issue":"10","key":"10.1016\/j.intimp.2023.109748_b0170","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.109748_b0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2023.109748_b0180","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1086\/429994","article-title":"Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis","volume":"41","author":"Algood","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.109748_b0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.micinf.2007.02.002","article-title":"Tumor necrosis factor is critical to control tuberculosis infection","volume":"9","author":"Jacobs","year":"2007","journal-title":"Microbes Infect."},{"issue":"15","key":"10.1016\/j.intimp.2023.109748_b0190","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.109748_b0195","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109748_b0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109748_b0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/vaccines8020300","article-title":"Antigen-Specific IFN-\u03b3\/IL-17-Co-Producing CD4+ T-Cells Are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine","volume":"8","author":"Choi","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.intimp.2023.109748_b0210","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/eji.201343680","article-title":"Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection","volume":"44","author":"Bandaru","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109748_b0215","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1101\/gad.1553707","article-title":"Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB","volume":"21","author":"Yang","year":"2007","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.intimp.2023.109748_b0220","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/0008-5472.939.65.3","article-title":"Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation","volume":"65","author":"Yang","year":"2005","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2023.109748_b0225","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer."},{"issue":"1","key":"10.1016\/j.intimp.2023.109748_b0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-019-0635-8","article-title":"Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes","volume":"7","author":"Lu","year":"2019","journal-title":"J. Immunother. Cancer."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:18:19Z","timestamp":1719231499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":46,"alternative-id":["S1567576923000711"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109748","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT3 regulation of Mtb-specific T cell function in active pulmonary tuberculosis patients","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109748"}}